Clinical Trial Update: Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition [Phase 1]

View source ↗

Summary

A Phase 1 trial update investigates inhibiting SGLT2 as a potential approach for pancreatic cancer, with the study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• SGLT2 inhibitor (not specified)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Pancreas Cancer, Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2023-01-17